Isabel Kalofonos's Insider Trades & SAST Disclosures

Isabel Kalofonos's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Crinetics Pharmaceuticals Inc
Isabel Kalofonos Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 100,000 100,000 - - Stock Option (Right to Buy)
Immunogen, Inc.
Isabel Kalofonos SVP & CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 284,250 284,250 - - Stock Option (Right to Buy)
Immunogen, Inc.
Isabel Kalofonos SVP & CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2023 47,375 47,375 - - Restricted Stock Unit
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades